...
首页> 外文期刊>AMERICAN JOURNAL OF HEMATOLOGY >Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC†
【24h】

Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC†

机译:修改后的非公开DIC诊断标准可预测公开DIC的早期阶段†

获取原文
获取原文并翻译 | 示例
           

摘要

Diagnostic criteria for non-overt disseminated intravascular coagulation (DIC) have been proposed by the International Society of Thrombosis and Hemostasis, but are not useful for the diagnosis of early phase of overt-DIC (pre-DIC). Therefore, in the current study the non-overt DIC diagnostic criteria were modified using the global coagulation tests, the change rate in the global coagulation tests and molecular hemostatic markers to detect the pre-DIC state and were prospectively evaluated in 613 patients with underlying DIC disease. The frequencies of patients with DIC (DIC positive), late onset DIC, and without DIC (DIC absent) were 29.5%, 7.2%, and 63.3%, respectively. The modified non-overt-DIC criteria can correctly predict 43/44 patients (97.7%) who were DIC absent at admission and became DIC positive, within a week (late onset DIC state). The mortality rate was higher in DIC positive compared with pre-DIC (37.6% vs. 22.7%, P 0.05) or DIC negative (37.6 vs. 13.7%, P 0.01). It was also significantly higher in pre-DIC compared with DIC negative (P 0.05). Thus, these modified non-overt DIC diagnostic criteria might therefore be useful for the diagnosis of early-phase DIC. © 2010 Wiley-Liss, Inc. Am. J. Hematol.
机译:国际血栓形成和止血协会已经提出了非公开的弥散性血管内凝血(DIC)的诊断标准,但对早期公开的DIC(pre-DIC)的诊断没有帮助。因此,在本研究中,使用整体凝血试验,整体凝血试验的变化率和分子止血标志物检测DIC前状态,对非公开的DIC诊断标准进行了修改,并对613例潜在DIC患者进行了前瞻性评估疾病。有DIC(DIC阳性),迟发性DIC和无DIC(无DIC)的患者的发生频率分别为29.5%,7.2%和63.3%。修改后的非公开DIC标准可以在一周内(迟发性DIC状态)正确预测入院时没有DIC并变为DIC阳性的43/44例患者(97.7%)。 DIC阳性的死亡率高于DIC前(37.6%比22.7%,P <0.05)或DIC阴性(37.6 vs. 13.7%,P <0.01)。与DIC阴性相比,DIC前的糖尿病也明显更高(P <0.05)。因此,这些修改后的非公开DIC诊断标准可能因此对早期DIC的诊断有用。 ©2010 Wiley-Liss,Inc.。 J. Hematol。

著录项

  • 来源
    《AMERICAN JOURNAL OF HEMATOLOGY》 |2010年第9期|p.691-694|共4页
  • 作者单位

    Department of Molecular and Laboratory Medicine, Mie University School of Medicine, Tsu, Japan;

    Department of Molecular and Laboratory Medicine, Mie University School of Medicine, Tsu, Japan;

    First Department of Surgery, University of Occupational and Environmental Health School of Medicine, KitaKyushu, Japan;

    Department of Internal Medicine, Takasaki National Hospital, Takasaki, Japan;

    Department of Internal Medicine, Teikyo University School of Medicine, Itabashi, Japan;

    Department of Emergency Medicine and Intensive Care, Graduate School of Medicine, Nagoya University, Nagoya, Japan;

    Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan;

    Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan;

    Department of Internal Medicine, Shibata Hospital-Niigata Prefectural Hospital, Shibata, Japan;

    Research Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan;

    Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan;

    Roald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool, United Kingdom;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号